by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Peptide Research
In the ever-expanding landscape of peptide research, KPV occupies a notable position. This 3 amino acids compound has been the subject of numerous studies investigating its role in alpha-MSH fragment and gut health. This article provides a detailed overview of current...
by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Research Guides
Thymosin Alpha-1, also known as Thymosin Alpha-1, is a 28 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in immune enhancement, dendritic cell activation, and related fields, yielding a...
by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Peptide Research
Research into LL-37 represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 37 amino acids compound has shown promise in areas ranging from antimicrobial peptide to wound healing, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Research Guides
The scientific community’s interest in Thymalin (Thymalin (Thymic Peptide)) has grown steadily over the past decade. Composed of thymic extract, this peptide has demonstrated notable effects in preclinical models related to thymus function and immune modulation....
by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Peptide Research
Among the many peptides under active investigation, Epitalon stands out for its unique properties and versatile research applications. Originally studied for its effects on telomerase activation, researchers have since discovered connections to anti-aging, longevity,...
by Proxiva Peptides | Mar 29, 2026 | Anti-Inflammatory, Peptide Research
Among the many peptides under active investigation, SS-31 stands out for its unique properties and versatile research applications. Originally studied for its effects on cellular energy, researchers have since discovered connections to cardiolipin binding, aging, and...
